Satellos Bioscience announced submission of a clinical research proposal to a Human Research Ethics Committee, or HREC, in Australia seeking regulatory authorization under their Therapeutic Goods Administration’s, or TGA’s, clinical trial notification, or CTN, scheme to conduct a first-in-human Phase 1 clinical trial of SAT-3247.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MSCLF: